Oracle Corporation (ORCL) is Attracting Investor Attention: Here is What You Should Know
Werte in diesem Artikel
Oracle (ORCL) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this software maker have returned -10%, compared to the Zacks S&P 500 composite's +1.3% change. During this period, the Zacks Computer - Software industry, which Oracle falls in, has gained 1.4%. The key question now is: What could be the stock's future direction?Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.For the current quarter, Oracle is expected to post earnings of $1.49 per share, indicating a change of +5.7% from the year-ago quarter. The Zacks Consensus Estimate has changed -5.3% over the last 30 days.The consensus earnings estimate of $6.25 for the current fiscal year indicates a year-over-year change of +12.4%. This estimate has changed -0.6% over the last 30 days.For the next fiscal year, the consensus earnings estimate of $6.92 indicates a change of +10.8% from what Oracle is expected to report a year ago. Over the past month, the estimate has changed -1.9%.With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Oracle.The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSProjected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.In the case of Oracle, the consensus sales estimate of $14.36 billion for the current quarter points to a year-over-year change of +8.1%. The $57.65 billion and $64.49 billion estimates for the current and next fiscal years indicate changes of +8.9% and +11.9%, respectively.Last Reported Results and Surprise HistoryOracle reported revenues of $14.06 billion in the last reported quarter, representing a year-over-year change of +8.6%. EPS of $1.47 for the same period compares with $1.34 a year ago.Compared to the Zacks Consensus Estimate of $14.12 billion, the reported revenues represent a surprise of -0.46%. The EPS surprise was -0.68%.Over the last four quarters, Oracle surpassed consensus EPS estimates two times. The company topped consensus revenue estimates two times over this period.ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S) and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an An is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.Oracle is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Oracle. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oracle Corporation (ORCL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Here
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Here
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Oracle Corp.
Analysen zu Oracle Corp.
Datum | Rating | Analyst | |
---|---|---|---|
10.12.2024 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.12.2024 | Oracle Sector Perform | RBC Capital Markets | |
10.12.2024 | Oracle Neutral | JP Morgan Chase & Co. | |
10.12.2024 | Oracle Buy | UBS AG | |
10.12.2024 | Oracle Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
10.12.2024 | Oracle Buy | UBS AG | |
10.12.2024 | Oracle Buy | Jefferies & Company Inc. | |
05.12.2024 | Oracle Buy | Jefferies & Company Inc. | |
30.09.2024 | Oracle Kaufen | DZ BANK | |
25.09.2024 | Oracle Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
10.12.2024 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.12.2024 | Oracle Sector Perform | RBC Capital Markets | |
10.12.2024 | Oracle Neutral | JP Morgan Chase & Co. | |
23.10.2024 | Oracle Sector Perform | RBC Capital Markets | |
07.10.2024 | Oracle Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Datum | Rating | Analyst | |
---|---|---|---|
13.12.2022 | Oracle Sell | Goldman Sachs Group Inc. | |
21.10.2022 | Oracle Sell | Goldman Sachs Group Inc. | |
19.03.2019 | Oracle Verkaufen | DZ BANK | |
17.09.2015 | Oracle Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.01.2015 | Oracle Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Oracle Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen